E.1 Medical condition or disease under investigation |
E.1.1 | Medical condition(s) being investigated |
colon cancer |
tumore del colon |
|
E.1.1.1 | Medical condition in easily understood language |
early colon cancer |
tumore del colon in fase iniziale |
|
E.1.1.2 | Therapeutic area | Diseases [C] - Cancer [C04] |
MedDRA Classification |
E.1.2 Medical condition or disease under investigation |
E.1.2 | Version | 14.1 |
E.1.2 | Level | PT |
E.1.2 | Classification code | 10009944 |
E.1.2 | Term | Colon cancer |
E.1.2 | System Organ Class | 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) |
|
E.1.3 | Condition being studied is a rare disease | No |
E.2 Objective of the trial |
E.2.1 | Main objective of the trial |
The main objective of this study is the evaluation of the feasibility and efficacy of ROLL to localize early colon cancers or scars of endoscopic polypectomies before minimally-invasive colon resections. |
L’obiettivo principale di questo studio è la valutazione della fattibilità e della efficacia della tecnica ROLL al fine di localizzare tumori precoci del colon o cicatrici da polipectomie endoscopiche antecedenti alla resezione al colon mini invasiva. |
|
E.2.2 | Secondary objectives of the trial |
Secondary objective is validation of ROLL technique to identify sentinel lymphnodes. |
Obiettivo secondario è la validazione della tecnica ROLL ai fini della identificazione dei linfonodi sentinella. |
|
E.2.3 | Trial contains a sub-study | No |
E.3 | Principal inclusion criteria |
Aged ≥ 18 years - Able to provide written informed consent - Diagnosis of early (T1) colon cancer or of endoscopically removed colonic polyp, with malignant histology (infiltration of the submucosa) and requiring surgical radicalization - Colon cancer suitable for resection by minimally invasive surgery - Patient fit for robotic-assisted or standard laparoscopic colon resection - American Society of Anesthesiologists (ASA) physical status ≤3 |
età ≥ 18 anni - Consenso Informato datato e firmato -diagnosi precoce di carcinoma del colon (T1) o di polipo del colon rimosso endoscopicamente con istologico di tumore maligno (infiltrazione della sottomucosa) e che richiede un intervento radicale - Tumore del colon che sia resecabile tramite chirurgia mini-invasiva - paziente che sia favorevole a una chirurgia laparoscopica standard o assistita da robot - ASA ≤ 3 |
|
E.4 | Principal exclusion criteria |
Benign lesions of the colon or of the rectum above 12 cm from the anal verge - Benign or malignant diseases of the anal canal - Synchronous colorectal tumours requiring multi-segment surgical resection - Co-existent inflammatory bowel disease - Clinical or radiological evidence of metastatic spread - Concurrent or previous diagnosis of invasive cancer within 5 years that could confuse diagnosis (non-melanomatous skin cancer or superficial bladder cancer treated with curative intent are acceptable) - History of psychiatric or addictive disorder or other medical condition that, in the opinion of the investigator, would preclude the patient from meeting the trial requirements - Pregnancy - Breast feeding - Participation in another colon cancer clinical trial relating to lesion mapping techniques |
- lesioni benigne del colon o del retto oltre i 12 cm dal margine anale - patologie benigne o maligne del canale anale - tumori colon rettali sincroni che richiedono una resezione chirurgica multi-segmentaria - contemporanea patologia infiammatoria intestinale - evidenza clinica o radiologica di diffusione metastatica - diagnosi concomitante o precedente di tumore invasivo entro i 5 anni che potrebbe confondere la diagnosi (sono accettati i tumori della pelle o superficiali trattati con intento curativo) - Storia di disturbi psichiatrici o di dipendenza o di altre condizioni cliniche che, a giudizio dello sperimentatore, precluderebbero il paziente dal soddisfare i requisiti dello studio - gravidanza - allattamento - partecipazione in altro studio clinico riguardante la tecnica di mappatura delle lesioni del colon |
|
E.5 End points |
E.5.1 | Primary end point(s) |
occurrence of positive radioguided identification of the primary tumour site or of the scar of endoscopic polypectomy |
identificazione del tumore primitivo o della cicatrice della polipectomia endosopica |
|
E.5.1.1 | Timepoint(s) of evaluation of this end point |
the evaluation is performed at the time of surgery and after the histopathologic examination. |
la valutazione avviene al momento dell'intervento chirurgico e dopo la verifica dell'esame istopatologico |
|
E.5.2 | Secondary end point(s) |
identification of sentinel lymphonodes |
identificazione dei linfonodi sentinella |
|
E.5.2.1 | Timepoint(s) of evaluation of this end point |
after the histopathologic examination |
dopo l'esame istopatologico |
|
E.6 and E.7 Scope of the trial |
E.6 | Scope of the trial |
E.6.1 | Diagnosis | Yes |
E.6.2 | Prophylaxis | No |
E.6.3 | Therapy | No |
E.6.4 | Safety | No |
E.6.5 | Efficacy | No |
E.6.6 | Pharmacokinetic | No |
E.6.7 | Pharmacodynamic | No |
E.6.8 | Bioequivalence | No |
E.6.9 | Dose response | No |
E.6.10 | Pharmacogenetic | No |
E.6.11 | Pharmacogenomic | No |
E.6.12 | Pharmacoeconomic | No |
E.6.13 | Others | No |
E.7 | Trial type and phase |
E.7.1 | Human pharmacology (Phase I) | No |
E.7.1.1 | First administration to humans | No |
E.7.1.2 | Bioequivalence study | No |
E.7.1.3 | Other | No |
E.7.1.3.1 | Other trial type description | |
E.7.2 | Therapeutic exploratory (Phase II) | Yes |
E.7.3 | Therapeutic confirmatory (Phase III) | No |
E.7.4 | Therapeutic use (Phase IV) | No |
E.8 Design of the trial |
E.8.1 | Controlled | No |
E.8.1.1 | Randomised | Information not present in EudraCT |
E.8.1.2 | Open | Information not present in EudraCT |
E.8.1.3 | Single blind | Information not present in EudraCT |
E.8.1.4 | Double blind | Information not present in EudraCT |
E.8.1.5 | Parallel group | Information not present in EudraCT |
E.8.1.6 | Cross over | Information not present in EudraCT |
E.8.1.7 | Other | Information not present in EudraCT |
E.8.2 | Comparator of controlled trial |
E.8.2.1 | Other medicinal product(s) | Information not present in EudraCT |
E.8.2.2 | Placebo | Information not present in EudraCT |
E.8.2.3 | Other | Information not present in EudraCT |
E.8.2.4 | Number of treatment arms in the trial | 1 |
E.8.3 |
The trial involves single site in the Member State concerned
| Yes |
E.8.4 | The trial involves multiple sites in the Member State concerned | No |
E.8.4.1 | Number of sites anticipated in Member State concerned | 1 |
E.8.5 | The trial involves multiple Member States | No |
E.8.6 Trial involving sites outside the EEA |
E.8.6.1 | Trial being conducted both within and outside the EEA | No |
E.8.6.2 | Trial being conducted completely outside of the EEA | No |
E.8.7 | Trial has a data monitoring committee | No |
E.8.8 |
Definition of the end of the trial and justification where it is not the last
visit of the last subject undergoing the trial
|
|
E.8.9 Initial estimate of the duration of the trial |
E.8.9.1 | In the Member State concerned years | 7 |
E.8.9.1 | In the Member State concerned months | 0 |
E.8.9.1 | In the Member State concerned days | 0 |